Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Proceedings of the American Thoracic Society 5:842-847 (2008)
© 2008 The American Thoracic Society
doi: 10.1513/pats.200807-075TH
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Roisin, R.
Right arrow Articles by Soriano, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Roisin, R.
Right arrow Articles by Soriano, J. B.

Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease

Roberto Rodríguez-Roisin1 and Joan B. Soriano2

1 Servei de Pneumologia (Institut del Tòrax), Hospital Clínic, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain; and 2 Program of Epidemiology and Clinical Research, Fundació Caubet-CIMERA Illes Balears, International Centre for Advanced Respiratory Medicine, and Ciber Enfermedades Respiratorias, Palma de Mallorca, Spain

Correspondence and requests for reprints should be addressed to R. Rodriguez-Roisin M.D., Servei de Pneumologia, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Spain. E-mail: rororo{at}clinic.ub.es

ABSTRACT

Chronic obstructive pulmonary disease (COPD) has been identified as an enormous growing worldwide health problem associated with long-term exposure to toxic gases and particles, most often related to cigarette smoking, heavily challenging our current millennium. The present article briefly reviews the evidence of the causes of death in COPD, while focusing on the impact of two of their most common and characteristic systemic effects, also named comorbidities—namely, lung cancer and cardiovascular disease—and drawing the attention to a new field of growing interest, namely the metabolic syndrome, and its potential interplay with the natural course of COPD. A comorbidity is defined as one or more distinct disorders (or diseases) in addition to COPD, regardless of whether this condition is or is not directly related to COPD, and irrespective of whether it is or is not part of the spectrum of the natural history of COPD.

Key Words: airflow limitation • chronic systemic inflammatory disorder • comorbidities • obesity • systemic inflammation






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Thoracic Society. 		 
CCM abstracts